
Menstrual health is a critical aspect of women's overall well-being, and menorrhagia represents a significant challenge that impacts millions of women worldwide. Understanding menorrhagia goes beyond simple medical terminology—it's about recognising a complex condition that can profoundly affect a woman's quality of life, physical health, and emotional well-being.
Menorrhagia is characterised by abnormally heavy or prolonged menstrual bleeding that extends beyond typical menstrual patterns. This condition is not merely an inconvenience but a potential indicator of underlying health issues that demand careful medical attention and comprehensive evaluation. Menorrhagia can occur during ovulatory and anovulatory cycles. It's crucial to separate menstruation effects by cycle. Ovulatory ovarian cycles cause regular menstruation, while anovulatory cycles cause irregularity or amenorrhoea. This distinction matters in management. Dysfunctional uterine haemorrhage can result from ovulatory or anovulatory periods. Other conditions, such as fibroids and adenomyosis, may cause excessive loss, although not usually. Except for anovulation, endocrine abnormalities do not cause significant menstrual loss. Contrary to popular belief, haemostatic diseases seldom induce menorrhagia unless in certain groups.
The most frequent clinical manifestation is excessive menstrual loss in regular periods. Patients with this issue ovulate regularly. Endometrium anomalies in these women include increased fibrinolytic activity and prostaglandin synthesis, according to laboratory study. Treatment is rationalised by these observations.
Behind such things, an end number of factors generally work, such as histopathological issues, body immune system, cell and its defence mechanism, dieting, lifestyle, and medication, all come under one roof. Thus it is crucial to be on the road to understanding menorrhagia and its pros and cons. Approximately 90% of women with a bleeding condition and 70% of women on anticoagulation experience heavy menstrual bleeding (HMB), also known as menorrhagia. Prediction of HMB includes clots ≥1 inch in diameter, low ferritin, and frequent pad or tampon changes. The work-up evaluates uterine/endometrial, ovulation, and coagulation disorders. Flooding and/or prolonged menses or a personal or family history of bleeding imply a bleeding condition and should be referred to a haematologist. History, pelvic examination, and/or pelvic imaging and laboratory testing for anaemia, ovulatory dysfunction, underlying bleeding problems, and excess anticoagulation will be performed. Reducing HMB is the therapy objective. In addition to ovulatory dysfunction, uterine pathology, or coagulation abnormalities, the treatment method will depend on the patient's age and desire for immediate or long-term fertility. Haemostatic treatment for HMB may be life-saving when utilised to address coagulation abnormalities and replace hormonal or surgical treatment.
Gynaecologists or other women's health care providers frequently start HMB work-ups. The workup determines if there are uterine/endometrial abnormalities, ovulation disorders, or coagulation issues. International Federation of Gynaecology and Obstetrics mnemonic for various disorders: PALM-COEIN (polyp; adenomyosis; leiomyoma; malignancy and hyperplasia; coagulopathy; ovulatory dysfunction; endometrial; iatrogenic; unclassified). Physical examination and history (menstrual, medical, bleeding, medicines, and recent trauma) are the initial work-up. Speculum and pelvic exams depend on patient age and doctor judgement. In a virginal adolescent, an abdomen ultrasound can replace the pelvic exam. Age and other history determine whether a patient has a Papanicolaou test, endometrial biopsy, or endocervical/vaginal swab for Chlamydia and gonorrhea. Clinical judgement (based on diagnostic suspicion and patient age) determines pelvic ultrasounds. The transabdominal technique is best for nonsexually active women, and the transvaginal approach is best for emotionally mature and sexually active women. Instilling intrauterine saline during transvaginal (endovaginal) ultrasonography (sonohysterography) enhances sensitivity for uterine abnormalities; however, it is mainly reserved for perimenopausal haemorrhage. Initial lab tests should include CBC and ferritin. If the patient has irregular monthly bleeding, a pregnancy test and laboratory testing for underlying disease that might cause ovulatory dysfunction, such as thyroid-stimulating hormone, prolactin, and serum androgens, should be done.
HMB with floods and/or delayed menses or a family history of bleeding suggests a bleeding condition and should be referred to a haematologist. Some symptoms can indicate a bleeding condition in women with HMB. They created a screening tool for health care practitioners. From 12 pages of questions and multiple variable logistic regression, the authors identified 8 questions, subsumed by 4 criteria, any of which predicted a bleeding condition with HMB:
Menstrual duration ≥7 days, with flooding or daily activity impairment in most cycles.
The screening technique alone detected bleeding problems with 82% sensitivity. Adding a visual blood assessment chart score >100 raised screening tool sensitivity to 95%, although findings would not be available at an initial visit. A PFA-100 (Tarrytown, NY) increased von Willebrand disease (VWD) screening tool sensitivity to 92%, but not other bleeding disorders.
While menstrual experiences vary among individuals, menorrhagia represents a significant deviation from normal physiological patterns. The condition goes beyond typical menstrual variations, creating substantial disruptions to daily life and potential health complications.
Uterine abnormalities contribute significantly to menorrhagia:
Underlying haematological factors can exacerbate menorrhagia:
Persistent heavy bleeding can lead to:
Menorrhagia can significantly impact:
Advanced Menorrhagia treatment approaches include:
Holistic management strategies:
Most individuals with dysfunctional uterine haemorrhage have no abnormalities found after history, examination, and investigation. Therefore, various aspects must be addressed while choosing a therapy (see box). Patient choice is vital. Involving patients in decision-making may improve therapy.19 However, patients must be informed to make acceptable decisions.
Menometrorrhagia, a complex condition involving both heavy and irregular bleeding, requires nuanced treatment:
Evidence-based medicine dominates clinical medicine. Evidence-based medicine is rationally using effective therapies within a reasonable management framework. The best remedies for heavy menstrual loss are not always prescribed by doctors. More than a third of UK general practitioners prescribe norethisterone [norethindrone], the least effective first-line medication, while just 1 in 20 prescribe tranexamic acid, usually the most successful. Not just primary care is affected. Less than 10% of gynaecologists in New Zealand utilise tranexamic acid, while 50% use luteal-phase progestogens.
Key strategies for menstrual health:
Seek medical consultation if experiencing:
Menorrhagia is not a condition of mere inconvenience but a significant health concern demanding comprehensive understanding, professional medical intervention, and personalised management strategies. Visit Ovum Hospitals for better healthcare advice and understanding.
Consult a healthcare professional if you experience bleeding lasting over seven days, require frequent pad changes, or pass large blood clots.
Untreated menorrhagia can potentially impact fertility by disrupting hormonal balance and reproductive system functionality.
While professional medical guidance is crucial, lifestyle modifications like balanced nutrition, stress management, and regular exercise can support menstrual health.
Common diagnostic approaches include blood tests, hormonal panels, ultrasound imaging, and potentially endometrial biopsy.
Many cases of menorrhagia can be effectively managed or treated with appropriate medical intervention and lifestyle adjustments.
Articles are a starting point. Book a consultation at a nearby centre or review packages with our team.